Abstract :

The primary aim of this research endeavor is to innovate a viable and user-friendly UV spectroscopic approach for quantifying formoterol and beclomethasone within metered dose inhalers (MDIs). These formulations, amalgamating Beclomethasone Dipropionate (BDP) and Formoterol Fumarate (FF), are extensively employed in managing bronchial asthma and chronic obstructive pulmonary diseases. Although analytical techniques already exist for assessing formoterol and beclomethasone in combination dry powder inhalers, this study concentrates on devising and validating a UV spectrophotometric method for simultaneously quantifying formoterol fumarate and Anhydrous Beclomethasone Dipropionate in Pressurized Metered Dose Inhalers (pMDIs).

The estimation is performed at a wavelength of 240 nm for Beclomethasone Dipropionate and 216 nm for Formoterol Fumarate. Both drugs demonstrate satisfactory linearity within the concentration range of 10-30 μg/ml for BDP and 0.3 to 0.9 μg/ml for FF at wavelengths of 240 nm (r^2=0.999) and 216 nm (r^2=0.999), respectively. The Beer-Lambert law is adhered to within the concentration range of 10-30 μg/ml for BDP and 0.3-0.9 μg/ml for FF.

The proposed methods are subjected to validation following ICH guidelines to assess accuracy, method precision, specificity, among other parameters. As a result, the proposed method can be effectively employed for the simultaneous determination of Beclomethasone Dipropionate and Formoterol Fumarate in routine analytical applications, offering a rapid and reliable solution for pharmaceutical analysis in the field.

---

Keywords :

Analytical Method, Beclometasone Dipropionate, Development and Validation, Formoterol Fumarate, pMDI, Spectroscopic.

---

References :

1. Federico Lavorini., Review Article., the Challenge of Delivering Therapeutic Aerosols to Asthma Patients., ISRN Allergy., Volume 2013, Article ID 102418, 17. http://dx.doi.org/10.1155/2013/102418
2. Beclomethasone API profile, February 2024 available from https://go.drugbank.com/drugs/DB00394.
3. Beclomethasone dipropionate, February 2024, available from: https://link.springer.com/article/10.2165/00003495-198428020-00002
4. Beclomethasone dipropionate, February 2024, available from: https://www.webmd.com/asthma/asthma-control-with-anti-inflammatory-drugs
5. Formoterol Fumarate API profile, February 2024 available from /https://go.drugbank.com/drugs/DB00983.
6. Formoterol Fumarate, February 2024, available from: https://link.springer.com/article/10.2165/00003495-199855020-00016
7. Formoterol Fumarate, February 2024, available from: http://web.squ.edu.om/medlib/med_cd/e_cds/Nursing%20Drug%20Guide/mg/formoterol_fumarate.htm
8. Indian Pharmacopoeia, government of India, ministry of health and welfare, volume-II, Ghaziabad, 2010, 873 & 1386.
9. US Pharmacopeia 30 NF 25. The United State Pharmacopoeial Convention, Rockvill, 2011, pp1487.
10. British Pharmacopeia, British Pharmacopeia commission, 2009, pp590 & 2677.
11. Validation of Analytical Procedures: Methodology (Q2R1), ICH Harmonised Tripartite Guidelines, 1996, pp 1-8.
12. P. Newman, Principles of metered-dose inhaler design, Respiratory Care. 50(9); (2005): 1177-1190.
13. Alaa Aldabet, et al., Molecular Dynamic Simulation Approach to Predict the Compatibility of Formulation Components of Salbutamol Sulfate Metered Dose Inhaler Free Off Ethanol. Research Journal of Pharmacy and Technology. 2023; 16(3):1385-1390. DOI: 10.52711/0974-360X.2023.00228.
14. Shihas Azeez, et al., Use of inhaler device in patients with Asthma or Chronic obstructive pulmonary disease: Errors and Adherence problems. Research Journal of Pharmacy and Technology 2020; 13(9):4130-4134. DOI: 10.5958/0974-360X.2020.00729.5.
15. Bhangale P. R. et al., Spectrophotometric Method for Simultaneous Estimation of Formoterol Fumarate and Mometasone Furoate in Respicaps, International Research Journal of Pharmacy 2013, 4 (6), 220-223.
16. Parth et al., simultaneous determination of beclomethasone Dipropionate and formoterol fumarate in rotacap Dosage form using two different Spectrophotometric methods, World Journal Pharmacy and Pharmaceutical Science, (2014), Vol 3, Issue 5, 611-623.
17. Kondawar et al., UV Spectrophotometric Method for Simultaneous estimation of Salmeterol xinafoate and Fluticasone propionate in Bulk and Dosage form International Journal of Pharmaceutical Technology and Research, (July-Sept 2011) Vol.3, No.3, 1801-1806.
18. Prasad et al., UV-Spectrophotometric Method Development and Validation for The Determination of Lornoxicam in Micro-sponges, International Journal of Applied Pharmacy., Vol.10, Issue 1, 2018.
19. Kharmate SV., Ingawale AU, Gurav NB, Jadhav RK, Kamble MU, Sutar SB, Patil SV., Development and Validation of UV spectrophotometric method for determination of chlorpropamide in bulk and formulation. IP International Journal of Comprehensive and Advanced Pharmacology 2022;7(3): 163-166.
20. Mahfuza Maleque, Md. Raquibul Hasan, Farhad Hossen, Sanjana Safi., Development and validation of a simple UV spectrophotometric method for the determination of levofloxacin both in bulk and marketed dosage formulations.,  Journal of Pharmaceutical Analysis 2012;2(6):454–457. http://dx.doi.org/10.1016/j.jpha.2012.06.004

21. Mohammad Yasir Peerzade, Shakeel Memon, Dr. Kiran Bhise and Ansari Irfan Aamer., Development and validation of UV-Visible spectrophotometric method for estimation of ritonavir in bulk and formulation., The Pharma Innovation Journal, 2019; 8(4): 30-34.
22. Doddi Srilatha,Mahesh Nasare, Borra Nagasandhya, Valluri Prasad, and Prakash Diwan., Development and Validation of UV Spectrophotometric Method for Simultaneous Estimation of Hesperidin and Diosmin in the Pharmaceutical Dosage Form. Hindawi Publishing Corporation ISRN Spectroscopy Volume 2013, Article ID 534830, 4 pages. http://dx.doi.org/10.1155/2013/534830
23. Kiran Sharma et al: Development and Validation of UV spectrophotometric method for the estimation of Curcumin in Bulk Drug and Pharmaceutical Dosage Forms. International Journal of Drug Delivery & Research., April-June 2012, 4 (2): 375-380.